PMVP (PMV Pharmaceuticals) Accounts Payable: $1.63 Mil (As of Mar. 2026)


PMVP PMV Pharmaceuticals Inc PMVP
34 GF Score
Price $1.24
! 2 Warning Signs
View Full Analysis

What is PMV Pharmaceuticals Accounts Payable?

PMV Pharmaceuticals PMVP +2.90% 34 Accounts Payable is $1.63 Mil as of Mar. 2026. GuruFocus rates PMVP with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

PMV Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was $1.63 Mil.

PMV Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2025 ($3.40 Mil) to Dec. 2025 ($3.16 Mil) and declined from Dec. 2025 ($3.16 Mil) to Mar. 2026 ($1.63 Mil).

PMV Pharmaceuticals's annual Accounts Payable increased from Dec. 2023 ($3.24 Mil) to Dec. 2024 ($6.58 Mil) but then declined from Dec. 2024 ($6.58 Mil) to Dec. 2025 ($3.16 Mil).

PMV Pharmaceuticals Accounts Payable Related Terms

PMV Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for PMV Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMV Pharmaceuticals Accounts Payable Chart

PMV Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 3.19 3.00 3.24 6.58 3.16

PMV Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.59 2.60 3.40 3.16 1.63
PMVP
34GF Score
PMV Pharmaceuticals Inc PMVP
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMV Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.63 Mil mean?
PMV Pharmaceuticals (PMVP) has a Accounts Payable of $1.63 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PMV Pharmaceuticals and its competitors.
Is PMV Pharmaceuticals' Accounts Payable too high?
PMV Pharmaceuticals' current Accounts Payable is $1.63 Mil. Overall, PMV Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does PMV Pharmaceuticals' Accounts Payable compare to MNOV and TCRX?
PMV Pharmaceuticals' Accounts Payable of $1.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PMV Pharmaceuticals and its competitors. PMV Pharmaceuticals's current Accounts Payable is $1.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMV Pharmaceuticals stock overvalued right now?
PMV Pharmaceuticals (PMVP) has a current Accounts Payable of $1.63 Mil. The current Accounts Payable is $1.63 Mil. PMV Pharmaceuticals' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PMV Pharmaceuticals (PMVP), the current Accounts Payable is $1.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMV Pharmaceuticals Business Description

Address 400 Alexander Park Drive, Suite 301, Princeton, NJ, USA, 08540
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
34GF Score

Get the complete analysis for PMVP

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.24
Price